Exchange Traded Concepts, LLC Relmada Therapeutics, Inc. Transaction History

Exchange Traded Concepts, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 17, 2023	BUY	$2.17 - $35.84 $19,052 - $314,675	8,780 Added 274.29%	11,981 $42,000
Q3 2022 Oct 07, 2022	SELL	$18.3 - $37.02 $3,239 - $6,552	-177 Reduced 5.24%	3,201 $119,000
Q2 2022 Jul 20, 2022	BUY	$16.5 - $30.34 $41,002 - $75,394	2,485 Added 278.28%	3,378 $64,000
Q1 2022 Apr 26, 2022	BUY	$16.72 - $26.99 $14,930 - $24,102	893 New	893 $24,000

12.3M

229K

138K

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $10.9M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

Stay updated on Exchange Traded Concepts, LLC with notifications on news.